Gait changes with anti-dementia drugs: a prospective, open-label study combining single and dual task assessments in patients with Alzheimer's disease

Beauchet, Olivier; Launay, Cyrille P; Allali, Gilles; Herrmann, François; Annweiler, Cedric

doi:10.1007/s40266-014-0175-3

Article scientifique

Anglais

Gait changes with anti-dementia drugs: a prospective, open-label study combining single and dual task assessments in patients with Alzheimer's disease

Contributeurs/tricesBeauchet, Olivier; Launay, Cyrille P; Allali, Gilles; Herrmann, François; Annweiler, Cedric

Publié dansDrugs & aging, vol. 31, no. 5, p. 363-372

Date de publication2014

Résumé

No comparison of anti-dementia drugs-related gait changes has been previously conducted combining single and dual task assessments.

Structure d'affiliation

Faculté de médecine / Section de médecine clinique / Département de réadaptation et gériatrie

Groupe de recherche

Citation (format ISO)

BEAUCHET, Olivier et al. Gait changes with anti-dementia drugs: a prospective, open-label study combining single and dual task assessments in patients with Alzheimer’s disease. In: Drugs & aging, 2014, vol. 31, n° 5, p. 363–372. doi: 10.1007/s40266-014-0175-3

Article (Published version)

Identifiants

PID : unige:40214
DOI : 10.1007/s40266-014-0175-3
PMID : 24683126

ISSN du journal1170-229X

541vues

2téléchargements

Création21/07/2014 09:33:00

Première validation21/07/2014 09:33:00

Heure de mise à jour14/03/2023 21:45:51

Changement de statut14/03/2023 21:45:51

Dernière indexation16/01/2024 11:51:13

Archive ouverte UNIGE

Gait changes with anti-dementia drugs: a prospective, open-label study combining single and dual task assessments in patients with Alzheimer's disease

No comparison of anti-dementia drugs-related gait changes has been previously conducted combining single and dual task assessments.

Informations techniques